2Seventy Bio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $13,534 | $8,967 | $12,435 | $10,684 |
Gross Profit | 7,766 | 5,514 | 5,829 | 4,507 |
EBITDA | -13,941 | -18,249 | -46,547 | -56,851 |
EBIT | -15,599 | -19,925 | -48,654 | -59,881 |
Net Income | -9,933 | 24,879 | -52,673 | -56,822 |
Net Change In Cash | 13,534 | 8,967 | 12,435 | 10,684 |
Free Cash Flow | -10,539 | -23,203 | -42,489 | -64,666 |
Cash | 59,984 | 111,864 | 56,792 | 74,958 |
Basic Shares | 52,263 | 55,011 | 52,071 | 51,383 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $100,387 | $91,496 | $54,522 | $248,122 |
Gross Profit | 98,288 | 65,277 | 52,005 | 242,726 |
EBITDA | -206,418 | -251,143 | 16,057 | -131,449 |
EBIT | -216,703 | -262,908 | -292,213 | -144,637 |
Net Income | -217,570 | -254,144 | -292,213 | -138,170 |
Net Change In Cash | 100,387 | 91,496 | 54,522 | 248,122 |
Cost of Revenue | -59,208 | 163,266 | ||
Free Cash Flow | -180,723 | -259,976 | -226,609 | -90,054 |
Cash | 74,958 | 71,032 | 130,414 | -127,603 |
Basic Shares | 49,276 | 35,637 | 23,585 | 23,287 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.19 |
2024-06-30 | $0.45 |
2024-03-31 | -$1.01 |
2023-12-31 | -$1.11 |
